Dermacrine – The Perfect addition to your stack
Do you need help supporting a raging sex drive, aggressive mental focus, and an intense appetite to fulfill your protein requirements? Perhaps you are you using Deca and having problems keeping ‘it’ hard, or running EQ and feeling lethargic and unmotivated, or using Anadrol or some related oral "pro-steroid" and lacking an appetite for food. These problems are typical for many athletes and bodybuilders when hormone levels become out of balance. Fortunately, Dermacrine can counter these problems by providing a significant boost in the essential male hormones.
Dermacrine is a topical cream that delivers high amounts of androgenic & anabolic hormones right through the skin. What makes Dermacrine so exciting is that it is not only a solid performance enhancing supplement on its own, but it can be stacked with just about any AAS cycle to increase gains and prevent many side effects. Let me explain…
Many don’t realize that there are over a dozen different natural hormones which act like testosterone to positively influence muscle gains, strength and libido.(1) Dermacrine delivers a hefty dose of DHEA and Pregenenolone, bio-identical precursors for the essential male hormones. More specifically, DHEA readily converts to the hormones androstenedione, androstenediol, and androsterone.(2-8) These are known as anabolic/androgenic hormones that are responsible for “all that is man” including libido, muscular development, aggression and recovery. Therefore, it is important to keep these hormones elevated with Dermacrine, especially during a steroid cycle when the production of these natural hormones are shut down!
Consider this -- Dermacrine is so powerful, users have compared it to using 150-200mg/wk of Injectable testosterone (TE).
To help control estrogenic side effects we’ve fortified Dermacrine with Resveratrol and 7,8 Benzoflavone – natural aromatase inhibitors that reduce conversion to estrogen. We’ve also designed Dermacrine to have minimal conversion to DHT, thus offering safety for those concerned with hair loss.
These properties make Dermacrine one outstanding product. We encourage you to visit the Primordial Performance website to learn more –
Testosterone Support Supplements for Men. Health, Libido, Masculinity
We also encourage you to learn more about Sustain Alpha as a PCT substitute for Clomid or Nolva without the side-effects.
1. Hormone Tree for hormone conversion pathways and functions.
2. Transformation in vitro of [4-14C ] dehydroepiandrosterone into 7-oxygenated derivatives by the normal human male and female skin tissue. Faredin, I., A. Fazekas, I. Toth, and M. Juslesz. J. Invest. Dermatol. 52:357. 1969
3. The metabolism of [4-14C] 5 androstene-3P, 17P-diol by normal human skin in vitro. Faredin, I., and I. Toth. Acta Med. Acad. Sci. Hung. 32:139. 1975.
4. Sebocytes are the key regulators of androgen homeostasis in human skin. M Fritsch, CE Orfanos, and CC Zouboulis J Invest Dermatol, May 1, 2001; 116(5): 793-800.
5. Transformation and conjugation of dehydroepiandrosterone by human skin. Berliner, D. L., and A. J. Gallegos. J. Clin. Endocrinol. 27:1214. 1967.
6. The formation of water soluble steroids by human skin. Berliner, D. L., J. R. Pasqu****i, and A. J. Gallegos. J. Invest. Dermatol. 50:220. 1968
7. The in vitro metabolism of dehydroepiandrosterone in human skin. I Faredin, JL Webb, and M Julesz Acta Med Acad Sci Hung, Jan 1967; 23(2): 169-79.
8. The metabolism of [4-14C] dehydroepiandrosterone by human skin in vitro. I. Transformation in vitro of [4-14C] dehydroepiandrosterone into Androst-4-ene-3,17-dione, testosterone and androsterone by normal human male and female skin slices. I Faredin, K Kokai, I Toth, AG Fazekas, and M Julesz Acta Med Acad Sci Hung, Jan 1970; 27(1): 95-102.
9. High bioavailability of dehydroepiandrosterone administered percutaneously in the rat C Labrie, M Flamand, A Belanger, and F Labrie J. Endocrinol., Sep 1996; 150: S107 - S118.
10. Effects of transdermal application of DHEA to men on the levels of steroids, gonadotropins and lipids. SULCOVÁ J, HILL M, HAMPL R, MA.EK Z, NOVÁ C EK A, C E.KA R, STÁRKA L Physiol Res 49: 685-693, 2000.
11. 5. Majeed, M. et al. US Patent #5,536,506 (1996), US Patent # 5,744,161 (1998), US Patent # 5,972,382 (1999), US Patent # 6, 054, 585 (2000) and International patents
NOTE: The new Oral Dermacrine Liqua-Vade is here! 11/25/09 .